Key result
Cardiac patients face a ~3-fold higher prevalence of depression compared with the general population.
Why the study?
Depression is a significant problem in cardiac patients, affecting mortality and morbidity, yet it often escapes detection and appropriate treatment.
Depression is highly prevalent in cardiac patients and requires appropriate screening and assessment by healthcare professionals.
Answers are grounded in this paper and cite their sources.
Depression warrants routine screening in cardiac care; leaves open optimal interventions to improve outcomes.
Depression is increasingly being recognized as a significant problem in cardiac patients, both as a predictor and an outcome. A growing body of evidence suggests that depression following a cardiac event is a significant factor for both mortality and morbidity [1] and that depression is also a significant predictor of coronary heart disease in initially healthy people [2]. Depression is a multifaceted disorder, encompassing a wide range of somatic, cognitive and mood symptoms, and it varies in intensity, duration, frequency and course, thus often rendering comparisons of data impossible [3]. Thus, although the prevalence of depressive symptoms or major depression in cardiac patients varies across studies it is around three times that of the general population. Yet, in many instances depression escapes detection and, as a consequence, patients do not receive a proper assessment and appropriate treatment [4]. A range of screening and assessment techniques can be used. The clinical diagnostic interview is the ideal but is often impractical and so, in routine clinical practice, the choice is usually either a self-report measure or reliance on a clinical judgement or feeling. A variety of self-report measures are available, the commonest being the Beck Depression Inventory (BDI) [5] or Hospital Anxiety and Depression Scale (HADS) [6], though others, developed specifically for cardiac patients [7,8] are appealing, particular in terms of performing a brief and rapid assessment. The choice of the measure will depend on the target patient population and the psychometric properties of the instrument concerned [4].
No takes yet. Share an insight, caveat, or question.
Thompson et al. (2006) conducted a review in Depression in cardiac patients. Depression screening and assessment was evaluated. The prevalence of depressive symptoms or major depression in cardiac patients is around three times that of the general population, highlighting the need for routine screening and assessment.
Synapse has enriched 10 related papers. Consider them for comparative context: